If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


_____ Brought to you by Thermo Fisher Scientific _____

Setting a New Standard for Analytical Rigor and Confident Identifications in Metabolomics



  September 8, 2020

  8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST




Metabolomics, the comprehensive analysis of all small molecules, endogenous and exogenous, in a biological system, affords revealing insights beyond what other omics technologies offer. Characterization of metabolic phenotypes enables biomarker discovery, disease taxonomy and tracking treatment effects. Quantitative comprehensive metabolome analysis requires analytical rigor in order to minimize technical variance across the analysis of larger sample sets aiding the detection of discriminating metabolites. The combination of high resolution accurate mass measurements with intelligence-driven fragmentation in a single workflow enables simultaneous confident identification of knowns and structural elucidation of unknown biomarkers.

In this presentation, we introduce the semi-targeted metabolomics workflow using a new compact HRAM Orbitrap mass spectrometer designed for exceptional usability and equipped with analytical capabilities for small molecule analysis.

Brought to you by:


Key Learning Objectives

  • Discover MS instrumentation designed for exceptional usability resulting in increased productivity
  • Recognize which analytical conditions generate high quality insightful metabolomics results
  • Explore innovations for small molecule analysis that lead to confident and trustworthy data
  • Review a metabolomics case study implementing a semi-targeted workflow for polar metabolites and lipids

Who Should Attend

  • Metabolomics researchers implementing large scale analyses
  • MS practitioners employing small molecule untargeted approaches for comprehensive analysis
  • Scientists new to the field of metabolomics applying biomarker discovery, global profiling, general phenotyping


Amanda Souza
Metabolomics Program Manager,
Thermo Fisher Scientific
Ioanna Ntai
Metabolomics Marketing Specialist,
Thermo Fisher Scientific


Kelly McSweeney
Contributing Editor,
C&EN Media Group